Evidence map›Paper›PMID 40894475›Full record

ArticleFrontiers in cardiovascular medicine2025

Case Report: Case of cardiac metastases from melanoma, treated by stereotactic radiotherapy, using a MICRA implant.

Mehdi Belbachir, Nicolas Danthez, David Rotzinger, Antiochos Panagiotis, Etienne Pruvot, Veronique Vallet, Maude Gondre, Gregoire Berthod, Sofia Latifyan, Rita Demicheli and 1 more

Abstract readCase Reports
In one paragraph

Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Mehdi BelbachirDepartment of Radiation Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Nicolas DanthezDepartment of Radiation Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
David RotzingerDepartment of Diagnostic and Interventional Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Antiochos PanagiotisDepartment of Diagnostic and Interventional Radiology, Lausanne University Hospital (CHUV) and University of Lausanne (UNIL), Lausanne, Switzerland.
Etienne PruvotDepartment of Cardiology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Veronique ValletDepartment of Radiation Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Maude GondreDepartment of Radiation Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Gregoire BerthodDepartment of Oncology, Valais Hospital, Sion, Switzerland.
Sofia LatifyanDepartment of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Rita DemicheliDepartment of Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.
Luis SchiappacasseDepartment of Radiation Oncology, Lausanne University Hospital (CHUV), Lausanne, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metastatic melanomas with prolonged survival are becoming increasingly common. We present the case of a 47-year-old man with melanoma who developed asymptomatic cardiac metastases, whose prognosis depended on their response to either systemic or focal treatment. Consequently, a CyberKnife radiotherapy treatment was performed using a pacemaker for tracking. Instead of using a pacemaker lead, we report here the successful use of a leadless pacemaker (Micra, Medtronic) as a fiducial reference for the tracking, which proved to be reproducible during all sessions. The planning target treatment volume was 161.58 cm

Indexed as

cardiac metastasiscase reportCyberKnifemelanomaradiotherapySBRT

Identifiers

PMID40894475
PMCPMC12394135

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.